Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective study | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective study

Wu DB, Jiang W, Wang YH, et al. Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective study. J Viral Hepat. 2019;26(3):316-322.

Publication Type:

Journal Article

Authors:

Wu, DB; Jiang, W; Wang, YH; et, al

Source:

J Viral Hepat, Volume 26, Issue 3, p.316-322 (2019)

Cited On:

Treatment-Naive Genotype 5 or 6

Export Citation:

RIS Format

Top